Synthesis of Peramivir Analogues as Influenza Neuraminidase Inhibitors
碩士 === 國立臺灣大學 === 化學研究所 === 103 === Influenza is a major threat to human health. Currently, zanamivir (Relenza), oseltamivir (Tamiflu) and peramivir (Rapiacta) are the main anti-influenza drugs to inhibit the viral neuraminidases. However, the bioavailability of peramivir is pretty low (2–3%), so th...
Main Authors: | Jo-Chi Yu, 余若綺 |
---|---|
Other Authors: | Jim-Min Fang |
Format: | Others |
Language: | zh-TW |
Published: |
2015
|
Online Access: | http://ndltd.ncl.edu.tw/handle/63041152974337189294 |
Similar Items
-
Clinical Effectiveness of Peramivir in Comparison with Other Neuraminidase Inhibitors in Pediatric Influenza Patients
by: Toshiyuki Hikita, et al.
Published: (2012-01-01) -
Peramivir: A novel intravenous neuraminidase inhibitor for treatment of acute influenza infections
by: Malak eAlame, et al.
Published: (2016-03-01) -
A Meta-Analysis Comparing the Efficacy and Safety of Peramivir with Other Neuraminidase Inhibitors for Influenza Treatment
by: Jui-Yi Chen, et al.
Published: (2020-02-01) -
Safety and efficacy of peramivir for influenza treatment
by: Hata A, et al.
Published: (2014-10-01) -
Design and synthesis of zanamivir analogues as efficient neuraminidase inhibitors
by: Anindya Das
Published: (2011)